MX2023013012A - Moduladores de proteina cinasa c (pkc)-theta. - Google Patents

Moduladores de proteina cinasa c (pkc)-theta.

Info

Publication number
MX2023013012A
MX2023013012A MX2023013012A MX2023013012A MX2023013012A MX 2023013012 A MX2023013012 A MX 2023013012A MX 2023013012 A MX2023013012 A MX 2023013012A MX 2023013012 A MX2023013012 A MX 2023013012A MX 2023013012 A MX2023013012 A MX 2023013012A
Authority
MX
Mexico
Prior art keywords
pkc
theta
modulators
compounds
syndromes
Prior art date
Application number
MX2023013012A
Other languages
English (en)
Spanish (es)
Inventor
Jérôme Meneyrol
Simon Richards
Jeremy Besnard
Peter Ray
Anthony Bradley
Catarina Santos
Virginie Suchaud
Original Assignee
Exscientia Ai Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exscientia Ai Ltd filed Critical Exscientia Ai Ltd
Publication of MX2023013012A publication Critical patent/MX2023013012A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Amplifiers (AREA)
  • Optical Communication System (AREA)
MX2023013012A 2021-05-06 2022-05-06 Moduladores de proteina cinasa c (pkc)-theta. MX2023013012A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB202106486 2021-05-06
PCT/GB2022/051167 WO2022234299A1 (en) 2021-05-06 2022-05-06 Pkc-theta modulators

Publications (1)

Publication Number Publication Date
MX2023013012A true MX2023013012A (es) 2024-03-25

Family

ID=82100804

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023013012A MX2023013012A (es) 2021-05-06 2022-05-06 Moduladores de proteina cinasa c (pkc)-theta.

Country Status (14)

Country Link
US (1) US20240239794A1 (cg-RX-API-DMAC7.html)
EP (1) EP4334316A1 (cg-RX-API-DMAC7.html)
JP (1) JP7874663B2 (cg-RX-API-DMAC7.html)
KR (1) KR20240024063A (cg-RX-API-DMAC7.html)
CN (1) CN117295738A (cg-RX-API-DMAC7.html)
AU (1) AU2022269348A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023022883A2 (cg-RX-API-DMAC7.html)
CA (1) CA3214088A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023003247A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023015005A2 (cg-RX-API-DMAC7.html)
IL (1) IL307669A (cg-RX-API-DMAC7.html)
MX (1) MX2023013012A (cg-RX-API-DMAC7.html)
PE (1) PE20250019A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022234299A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240262821A1 (en) * 2021-05-06 2024-08-08 Exscientia Al Limited PKC-Theta Modulators
CN118772140B (zh) * 2023-04-07 2026-04-17 四川大学 一类化合物及其在治疗hDHODH介导的疾病中的用途
WO2025255294A1 (en) * 2024-06-06 2025-12-11 Bristol-Myers Squibb Company Pkc-theta inhibitors, compositions, and methods of use
WO2025255298A1 (en) * 2024-06-06 2025-12-11 Bristol-Myers Squibb Company Pkc-theta inhibitors, compositions, and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173635B2 (en) * 2007-11-02 2012-05-08 Vertex Pharmaceuticals Incorporated Kinase inhibitors
GB0920382D0 (en) 2009-11-20 2010-01-06 Univ Dundee Design of molecules
AU2010352577A1 (en) * 2010-05-05 2012-01-19 Vertex Pharmaceuticals Incorporated 4 substituted pyrazolopyrimidines useful as PKC-theta inhibitors
RU2016129380A (ru) 2013-12-20 2018-01-25 СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Замещенные диаминопиримидильные соединения, их композиции и способы лечения с их участием
EP3976612A4 (en) * 2019-05-28 2023-04-26 Mankind Pharma Ltd NEW COMPOUNDS FOR INHIBITION OF JANUS KINASE 1
US20240262821A1 (en) * 2021-05-06 2024-08-08 Exscientia Al Limited PKC-Theta Modulators

Also Published As

Publication number Publication date
WO2022234299A1 (en) 2022-11-10
JP2024518447A (ja) 2024-05-01
AU2022269348A1 (en) 2023-10-26
CO2023015005A2 (es) 2024-02-05
US20240239794A1 (en) 2024-07-18
CA3214088A1 (en) 2022-11-10
EP4334316A1 (en) 2024-03-13
IL307669A (en) 2023-12-01
JP7874663B2 (ja) 2026-06-16
PE20250019A1 (es) 2025-01-07
KR20240024063A (ko) 2024-02-23
BR112023022883A2 (pt) 2024-01-23
CN117295738A (zh) 2023-12-26
CL2023003247A1 (es) 2024-04-26

Similar Documents

Publication Publication Date Title
MX2023005928A (es) Moduladores de malt-1.
MX2023013013A (es) Moduladores de proteina cinasa c (pkc)-theta.
PH12020552206A1 (en) Pyrazole derivatives as malt1 inhibitors
PH12021552759A1 (en) Substituted cycloalkyls as modulators of the integrated stress pathway
MX392673B (es) Derivados de pirazol como inhibidores de malt1
PH12020552207A1 (en) Pyrazole derivatives as malt1 inhibitors
MY207223A (en) Prodrug modulators of the integrated stress pathway
UY38685A (es) Moduladores de la vía de tensión integrada
MX2025007384A (es) Inhibidores de malt1
BR112023022883A2 (pt) Moduladores de pkc-teta
MX2020006290A (es) Dinucleotidos ciclicos como agonistas de sting.
MY208545A (en) Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith
MX2021012706A (es) Inhibidores de dihidroorotato deshidrogenasa.
MX2021012417A (es) Anillos de piridina que contienen derivados como inhibidores de malt1.
PH12020552172A1 (en) Cyclic dinucleotides as sting agonists
MX2023008589A (es) Compuestos moduladores de gcn2 y usos de los mismos.
CA3196916A1 (en) Modulators of the integrated stress pathway
WO2021226206A3 (en) Cannabinoid receptor type 2 (cb2) modulators and uses thereof
MX2022002470A (es) Inhibidores de dihidroorotato deshidrogenasa sustituidos con urea.
MX2025007469A (es) Moduladores lsd1
MX2022004335A (es) Biarilos como inhibidores de la dihidroorotato deshidrogenasa.
MX2021014582A (es) Derivados de diazepinona como moduladores del ensamblaje de la capside.
MX2021014580A (es) Derivados heterociclos condensados como moduladores de ensamblaje de la capside.
MX2021014577A (es) Difluoroazepanos como moduladores del ensamblaje de la cápside del vhb.
MX2021014578A (es) Azepinas como moduladores del ensamblaje de la cápside del vhb.